Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets, Volume 15 - Number 1
Novel Synthetic Pharmacophores Inducing a Stabilization of Cellular Microtubules
, 15(1): 2 - 13Anne Martinez, Emmanuelle Soleilhac, Caroline Barette, Renaud Prudent, Gustavo J. Gozzi, Emilie Vassal-Stermann, Catherine Pillet, Attilio Di Pietro, Marie-Odile Fauvarque and Laurence Lafanechere
DOI: 10.2174/1568009615666141215154149
Novel Synthetic Pharmacophores Inducing a Stabilization of Cellular Microtubules
Procyanidin B2 3,3″-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways
, 15(1): 14 - 26Rahul Kumar, Gagan Deep, Michael F. Wempe, Rajesh Agarwal and Chapla Agarwal
DOI: 10.2174/1568009614666141229102254
Procyanidin B2 3,3″-di-O-gallate Inhibits Endothelial Cells Growth and Motility by Targeting VEGFR2 and Integrin Signaling Pathways
Clinicopathological Characteristics of Chinese Colorectal Cancer Patients under 30 Years of Age: Implication in Diagnosis and Therapy
, 15(1): 27 - 34Changpeng Zhu, Meng Ji, Weiping Dai, Changhong Ye, Zhiqian Hu, Jian Shi, Xin Zeng and Yong Lin
DOI: 10.2174/1568009615666150101115800
Clinicopathological Characteristics of Chinese Colorectal Cancer Patients under 30 Years of Age: Implication in Diagnosis and Therapy
Potential Anti-cancer Drugs Commonly Used for Other Indications
, 15(1): 35 - 52Veronika Hanusova, Lenka Skalova, Vera Kralova and Petra Matouskova
DOI: 10.2174/1568009615666141229152812
Potential Anti-cancer Drugs Commonly Used for Other Indications
MYC-mediated Synthetic Lethality for Treatment of Hematological Malignancies
, 15(1): 53 - 70Xin Li, Xin A. Zhang, Wei Xie, Xiaoqing Li and Shiang Huang
DOI: 10.2174/1568009615666150105120055
MYC-mediated Synthetic Lethality for Treatment of Hematological Malignancies
Nano-pharmaceutical Formulations for Targeted Drug Delivery against HER2 in Breast Cancer
, 15(1): 71 - 86Sams M.A. Sadat, Soodabeh Saeidnia, Adil J. Nazarali and Azita Haddadi
DOI: 10.2174/1568009615666150105115047
Nano-pharmaceutical Formulations for Targeted Drug Delivery against HER2 in Breast Cancer
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net